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Abstract
Meibomian gland dysfunction (MGD) is the major cause of evaporative dry eye disease (EDED) and dysfunction
is widely thought to mechanistically involve ductal hyperkeratinization, plugging and obstruction. This review
re-evaluates the role of hyperkeratinization in MGD based on more recent findings from mouse models. In
these studies, eyelids from normal young and old mice or mice exposed to desiccating stress were evaluated
by immunofluorescent tomography and 3-dimensional reconstruction to evaluate gland volume, expression of
hyperkeratinization markers and cell proliferation or stimulated Raman scattering (SRS) microscopy to assess
lipid quality. Results indicate that aging mice show dropout of meibomian glands with loss of gland volume
and a forward migration of the mucocutaneous junction anterior to the gland orifice; similar age-related
changes that are detected in human subjects. Atrophic glands also showed evidence of epithelial plugging of
the orifice without the presence of hyperkeratinization. Mice exposed to desiccating stress showed hyperproliferation
of the meibomian gland and ductal dilation suggesting a marked increase in lipid synthesis. Lipid quality was also
affected in EDED mice with an increase in the protein content of lipid within the duct of the gland. Overall, age-related
changes in the mouse show similar structural and functional correlates with that observed in clinical MGD without
evidence of hyperkeratinization suggesting that gland atrophy may be a major cause of EDED. The response of the
meibomian gland to desiccating stress also suggest that environmental conditions may accelerate or potentiate
age-related changes.
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Introduction
Meibomian glands are modified, holocrine, sebaceous
glands that are embedded in the tarsal plate of the both
the upper and lower eyelid [1], and excrete lipid onto
the surface of the eye to form the lipid layer of the tear
film to reduce aqueous tear evaporation [2]. Dysfunction
of the meibomian gland (MGD) is a common eyelid
disorder having a widespread prevalence of 39–50 % in
the US population with the incidence increasing with
age [3–6]. MGD is also a major cause of evaporative dry
eye disease (EDED) [7], with loss of glands resulting in
decreased tear film lipid, increased aqueous tear evapor-
ation [2], and increased tear film osmolarity [8]; leading to
ocular surface changes, unstable tear film and blepharitis
[9, 10]. While patients with EDED and MGD comprise
from 37 to 47 % of the average Ophthalmologists and
Optometrists practice, management of this disease is
primarily palliative and includes warm compresses, anti-
microbial and anti-inflammatory therapy [4].
Currently, three forms of MGD are recognized: hyperse-
cretory MGD, hyposecretory MGD and obstructive MGD,
with the later form considered to be the most common
[11, 12]. Based on clinical and animal studies [13–19],
obstructive MGD is thought to involve hyperkeratinization
of the meibomian gland duct leading to ductal occlusion
and plugging of the meibomian gland orifice that then
causes cystic dilation of the duct and a ‘disuse atrophy’ of
the acini that is detected as gland ‘dropout’ on transillu-
mination infrared photography (meibography) [20].
Recent studies of human and mouse meibomian glands
have identified specific age-related changes including de-
creased acinar cell proliferation, gland atrophy and altered
peroxisome proliferator-activated receptor gamma (PPARγ)
expression and localization [21, 22]. Since PPARγ is a major* Correspondence: JJester@uci.edu
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regulator of lipogenesis and is required for sebocyte and
adipocyte differentiation [23], these findings suggest that
during aging there is a decline in meibocyte differentiation
and lipid synthesis that leads to an age-related meibomian
gland dysfunction (ARMGD) causing meibomian gland
dropout and abnormal lipid excretion. More recent studies
evaluating meibomian gland function in the mouse further
support a role for meibomian gland atrophy as a potential
major cause for clinical MGD and EDED. These experi-
mental findings are inconsistent with the conventional
theory of hyperkeratinization and duct obstruction as the
mechanistic basis for MGD. This review presents the
original evidence for keratinization playing a role in the
development of obstructive MGD as well as discuses
recently published findings on keratinization in ARMGD
and the effects of desiccating stress on gland function.
Based on this review, we hypothesize that defects in
meibomian gland acinar differentiation and function lead-
ing to gland atrophy play a critical role in the development
of clinical MGD as opposed to a mechanism involving
hyperkeratinization leading to duct obstruction.
Hyperkeratinization and meibomian gland dysfunction
In 1979, while studying a non-human primate model of
polychlorinated biphenyl (PCB) poisoning in human,
Ohnishi et al. showed that the ocular manifestations of
this disease was associated with hyperkeratosis of the
meibomian gland duct leading to ductal dilation and
filling with keratinized cells [18]. Since it was generally
believed at that time that obstruction and dilation of the
meibomian gland did not involve keratinization [24], it
was suggested by Ohnishi that keratic cyst formation
was a characteristic of PCB poisoning. Later, in 1980
and 1981, Korb and Henriquez published their findings
on contact lens intolerance and the association with
MGD involving deficient secretions leading to ocular
dryness and fluorescein staining of the cornea [19, 25].
In this study, meibomian gland secretions were collected
from contact lens intolerant patients and age and sex
matched contact lens tolerant patients and evaluated by
cytological staining. Unlike samples from contact lens
tolerant patients, they observed that contact lens intoler-
ant patients showed keratotic plugging of the meibomian
glands and the presence of desquamated epithelial cells
in the stagnated excretions taken from the glands. As a
mechanistic basis for their findings, they proposed that
internal obstruction and plugging of the meibomian
gland duct may be related to increased epithelial turn-
over and the accumulation of desquamated epithelial
cells, particularly near the lid margin.
Later in 1981, a histologic and ultrastructural study of
the human, primate, rabbit and steer meibomian gland
was published showing that the ductal epithelium of the
gland exhibited features similar to keratinized epidermis,
including a thin horny layer, keratohyaline granules and
lamellar bodies; albeit a well developed stratum corneum
and stratum granulosum were absent except at the orifice
of the gland [1]. These structural features bore distinct
similarities to that of the sebaceous gland suggesting that
similar pathogenic mechanisms involving keratinization
may play a role in meibomian gland disease.
In 1982, a rabbit model of meibomian gland hyperker-
atinization following long term topical epinephrine treat-
ment was reported along with a novel imaging approach
to sequentially document the progression of disease using
transillumination biomicroscopy, i.e., meibography [16].
As shown in Fig. 1, meibography as originally described
by Tapie [26], detects primarily the individual acini of the
meibomian glands as they cluster around the central duct
(a, small arrows). In normal eyelids, the orifice of the
glands remains indistinct (a, arrowheads), while rabbits
eyes treated with 2 % epinephrine for 1–2 months
showed marked darkening in the region of the gland
orifice (b, arrowheads). On histological evaluation, the
dark regions identified by meibography were associated
with hyperkeratinization and plugging of the orifice of
the gland and the beginning of ductal dilation. Contin-
ued exposure to 2 % epinephrine resulted in progressive
hyperkeratinization of the gland and the appearance of
dark, cystic structures that obscured the normal appear-
ance of the gland and was consistent with the beginning
of acinar atrophy and replacement with fully keratinized
epithelium. Long-term treatment resulted in complete re-
placement of the gland with a dark keratotic cyst as seen
by meibography (D). Of particular note in this study was
the finding that ductal plugging by hyperkeratinzation was
first detected using meibography by the distinct darkening
at the orifice of the gland.
Also in 1982, Gutgesell et al. reported on the histologic
findings from 7 patients exhibiting MGD who underwent
ectropion or entropion repair [13]. Pathologic samples
showed dilation of the central meibomian gland duct with
evidence of acinar atrophy and the presence of regional
"hyperkeratinization" or thickening of the ductal epithelium.
Together these findings along with other confirmatory
reports have formed the basis for a putative pathogenic
mechanism for MGD involving hyperkeratinization of the
meibomian gland ductal epithelium leading to obstruction
of the meibomian gland orifice, stasis of the gland, cystic
dilation and then atrophy of the secretory acini as exten-
sively summarized by the recent International Workshop
on Meibomian Gland Dysfunction [12]. While this model is
widely accepted, there are several observations in patients
with MGD that are not explained by hyperkeratinization.
Inconsistencies in the hyperkeratinization model
As shown in Fig. 2, the hallmark of MGD is dropout of the
acini within the eyelid of patients suffering chronic
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blepharitis compared to normal individuals [27]. In general,
the severity of meibomian gland dropout coincides with
decrease quality of the meibomian gland excreta, showing a
significantly high correlation (r = 0.882, p < 0.001) in one
reported study of 36 sequential oculoplastic patients [21].
Intuitively, based on the hyperkeratinization model one
might expect a much lower correlation if changes in lipid
quality and increased excreta viscosity following duct
obstruction preceded ductal dilation and acinar atrophy.
Such is the apparent case for PCB poisoning, where
hypersecretion of a whitish substance easily expressed
from the meibomian glands is one of the first ocular
symptoms detected in patients and non-human primates
treated for 1 month with PCB [18].
Another marked difference between animal models of
hyperkeratinization induced MGD and clinical MGD is
the absence of any meibographic changes in the orifice
of the gland in patients. Unlike the rabbit epinephrine-
induced MGD model, where the first signs of ductal
obstruction can be detected by focal darkening at the
gland orifice [16], similar changes are not observed in
chronic blepharitis patients [27]. Furthermore, while
progressive keratinization of the meibomian gland in the
rabbit is detected by the development of dark cystic
structures that obscure acinar detail, chronic blepharitis
patients show simply continued loss of acini. Even more
recent publications using non-invasive and non-contact
imaging systems, analysis of MGD continues to focus
on gland dropout, the severity of which has been shown
to be highly correlated with meibomian gland lipid
changes [28, 29].
While these differences could be species specific, the
biochemical signatures between the hyperkeratiniza-
tion rabbit model and chronic blepharitis associated
MGD are also very different. In rabbits, cytokeratin
proteins characteristic of fully keratinized, skin epider-
mis (65–67 kD) are not detected in the excreta from
normal eyelids, or eyelids not showing meibographic
evidence of epinephrine-induced MGD [14, 30]. However,
these cytokeratin markers for keratinization can be
detected in excreta from rabbits showing ductal plugging,
and are present in increasing amounts as hyperkeratiniza-
tion of the glands progress. By contrast, evaluation of
cytokeratins in excreta from MGD patients failed to detect
keratin markers for hyperkeratinization [31]. Although
MGD excreta contained a 10 % increase in the amount of
detectible cytokeratins, these were associated with ductal
keratins and not fully keratinized epithelia. The authors
suggest that the failure to detect keratinization markers
could be due to increase susceptibility to degradation of
higher molecular weight keratin, a similar explanation for
the absence of these markers in normal excreta. While
keratinization markers have been detected using prote-
omic analyses [32], it should be noted that MGD patients
Fig. 1 Meibography of the rabbit eyelids from normal (a), and 2 % epinephrine treated eyes for 1–2 months (b), 3–4 months (c) and 6 months (d).
Normal glands (a. curved arrow) appear as grape-like clusters of individual acini (small arrow) with indistinct gland orifices (a, arrowheads). After 1–2
months of treatment, the orifices of the glands become detectible as dark spots at the leading edge of the glands (b, arrowheads). Progression of
hyperkeratinization into the gland is detected by 3–4 months after treatment as large, dark cystic structure that obscure the normal acini (c, arrows).
After six months of treatment the meibomian glands are replaced by large, dense keratic cysts (d). Magnification A-C: 24x and D: 10x
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do not show meibographic evidence of ductal plugging
similar to rabbits, and therefore the failure to detect
keratinization markers on immunoblotting is consistent
with the rabbit findings. Although it is clear that Korb and
Henriquez identified squamous cells within excreta from
MGD patients [25], it is possible that these cells were
not fully keratinized (a claim not made by Korb and
Henriquez) and were rather derived from non-keratinized
ductal epithelial cells.
Age-related meibomian gland dysfunction and
keratinization
Recently, an age-related meibomian gland dysfunction
(ARMGD) leading to acinar dropout and significantly
decreased gland size has been identified in aging mice
[22, 33]. To evaluate the role of gland keratinization in
ARMGD, immunofluorescent tomography (IT) has been
used to localize and quantify changes in keratinization
markers, comparing young mice (5 month-old) to older
mice (2 year-old) [34]. IT is a novel imaging para-
digm that uses plastic embedding, serial thin section-
ing of large tissue blocks (3 mm × 3 mm) and
repetitive immunofluorescent staining of individual
sections to 3-dimensionally reconstruct at high resolution
(voxels = 0.44 μm × 0.44 μm × 2.0 μm) large portions of
the mouse eyelid containing multiple meibomian glands
(for details please see reference [35]).
As shown in Fig. 3, individual sections can be sequentially
stained to localize multiple cytokeratins and determine
where in the meibomian gland cytokeratin markers for fully
keratinized epithelium (CK1) compared to markers for
non-keratinized epithelium (CK6) are expressed. In young
mice (A), CK1 staining extends from the fully keratinized
epidermis into the ductal epithelium at the orifice and then
extends posteriorly toward the conjunctiva. CK1 staining
abruptly stops where CK6 staining begins, which is
posterior to the gland orifice in young mice; indicating
the location of the mucocutaneous junction or the
region where fully keratinized skin epidermis meets
non-keratinized conjunctiva. Importantly, it should also
be noticed that in young mice the suprabasal ductal
epithelium of the meibomian gland is stained by CK6
similar to conjunctiva, indicating that while ultrastructurally
there are features suggestive of full keratinization, ductal
epithelium is non-keratinized. Similar cytokeratin staining
patterns in the mouse have been reported by others [36].
In tissue sections from older mice (b), CK1 staining
appears to stop at the orifice of the gland (arrowhead),
Fig. 2 Meibography of a patient suffering from chronic blepharitis (a) showing extensive meibomian gland acinar dropout compared to a normal
individual (b)
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suggesting an anterior shift in the mucocutaneous junc-
tion. Additionally, in some glands the orifice appeared
plugged with epithelial cells that stained with antibodies
to CK6 and not CK1 (b, arrowhead). 3-Dimensional
reconstructions confirmed the large size of the meibomian
glands in young mice and the marked decrease in size
with aging mice (red arrowhead, c and d, respectively).
Additionally, surface rendering for CK1 (e and f, gold)
combined with CK6 (e and f, green) more clearly identified
the location of the mucocutaneous junction posterior to
the meibomian gland orifice in young mice (e). By contrast,
the mucocutaneous junction had moved anteriorly in older
mouse eyelids and in some cases did not surround the
entire orifice (f, arrow).
There are two very interesting observations regarding
ARMGD in the mouse that are inconsistent with the
proposed mechanism of hyperkeratinization, ductal
obstruction and MGD. First, epithelial plugs were
detected at the orifice of some of the glands that appear
to be comprised of non-keratinized ductal epithelial
cells. The presence of epithelial plugging is consistent
with the observations by Korb and Henriquez that
excreta from patient with MGD contain desquamated
cells and at times epithelial ductal plugs [19]. However,
since Korb and Henriquez did not specifically stain for
the presence of keratinization, it is not clear that the
epithelial ductal plugs that were observed represented
"keratotic plugs" as described in their report. The find-
ing that plugs were comprised of non-keratinized
ductal epithelium also supports the observations by
Ong et al. that excreta from MGD patients does not
contain cytokeratins characteristic of fully keratinized
skin [31], and is not what is observed in hyperkeratini-
zation models of MGD [30].
Fig. 3 Immunofluorescent Tomography of eyelids from 5 month-old (a, c, e) and 2 year-old (b, d, f) mice. In single plastic sections (a and b)
sequentially stained for cytokeratin 1 (CK1, red), 5 (CK5, green) and 6 (CK6, blue) the mucocutaneous junction is detected by the transition from fully
keratinized skin (CK1 positive) to non-keratinized conjunctiva (CK6 positive). Note the presence of ductal plugging with CK6 positive epithelial cells in
the 2 year-old eyelid (arrowhead). Volume reconstruction of anti-CK5 staining of eyelids (c and d) with segmentation of the meibomian glands (green)
from skin epithelium (white) shows marked atrophy of the meibomian glands in the 2 year-old compared to the 5 month-old eyelid (red arrowhead).
Reconstruction of young and old eyelids (e and f) stained for CK1 epidermis (gold) and CK6 conjunctiva (green) show the anterior migration of the
mucocutaneous junction (e and f, arrows)
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Secondly, ARMGD in the mouse is associated with an
anterior displacement of the mucocutaneous junction. A
very similar anterior displacement is detected in aging
humans as identified by fluorescein staining of Marx line
[37]. More importantly, the report by Yamaguchi et al.
indicates that there is a very strong correlation with the
position of Marx line and both meibomian gland drop-
out and abnormal meibomian gland secretion. While it
is not clear whether the development of MGD precedes
or is caused by this forward displacement, it is clear that
ARMGD in the mouse shows distinctly similar structural
changes in the mucocutaneous junction as observed in
aging subjects and that meibomian gland dropout and
anterior displacement of the mucocutaneous junction
are likely closely related. Another, and perhaps more
important point that can be deduced from these findings
is that hyperkeratinization does not play a role in either
the migration of Marx line/mucocutaneous junction or
ARMGD. If hyperkeratinization played a role, then one
might expect a posterior migration of the mucocutaneous
junction, and not a movement away from the gland orifice.
Effects of desiccating stress on meibomian gland function
Over the past decade a mouse model of desiccating stress
has become widely popular for assessing the underlying
mechanism of ocular surface inflammation associated with
dry eye and potential therapeutic treatments [38, 39]. While
studies have focused on changes in the conjunctival and
corneal ocular surface, a recent report has evaluated the
changes in the meibomian gland in mice exposed to the
desiccating stress environment [40]. In this study, immu-
nostaining for Ki67, a marker for cell cycle entry and cell
division, was used to assess meibomian gland acinar and
ductal proliferation. To assess changes in lipid quality,
stimulated Raman scattering (SRS) microscopy was used
to image vibrational signals from specific chemical bonds
associated with protein (amide I) and lipid (CH2). SRS is a
nonlinear optical technique that is non-destructive and
non-invasive and can be used to identify specific chemical
vibrational signals in cells, tissues or tissue sections that
can later be stained to more precisely localize chemical
patterns, particularly lipids (for details of SRS imaging
please references [40, 41]).
As shown in Fig. 4, meibomian glands from normal mice
show a low rate of proliferation with less than 20 % of the
cells appearing to be cycling as detected by immunostaining
for Ki67 (a, green). By comparison, meibomian glands from
mice exposed to desiccating stress show a significant
increase in the number of cells that are cycling, averaging
64.4 and 66,6 % after 5 and 10 days exposure (p < 0.005).
This finding indicates that meibomian glands are affected
in the desiccating stress model, and show a marked up-
regulation of cell proliferation, suggesting that there is a
compensatory increase in lipid production in response to
the environmental stress. Probing of tissue sections from
normal eyelids using SRS microscopy (c) followed by stain-
ing for actin (d, Phalloidin) and nuclei (d, DAPI) showed
lipid signals within the gland that appeared weaker in re-
gions identified as acini (ac, arrows) and much stronger in
regions identified as ducts (dt). Interestingly, acinar regions
all had a high protein to lipid ratio that gradually decreased
moving from the ductule to the central duct to the orifice
of the gland (e). This finding suggests that lipid synthesized
by the meibomian gland undergoes a maturation process
where protein is gradually and continually removed from
the lipid prior to exiting the orifice of the gland.
While the protein to lipid ratio in meibomian glands
from control mice showed a decreasing ratio from the acini
to the central duct (f), meibomian glands from mice
exposed to desiccating stress for 5 days (g) and 10 days (h)
showed no decrease from acini to central duct, and in some
cases showed increased protein (g, blue line). This finding
suggests that increased cell proliferation, acinar differenti-
ation, and cell turnover induced by the desiccating stress
model may overwhelm the ability of the gland to remove
protein from the lipid prior to expression from the gland.
Retention of protein most likely will have a profound effect
on the lipid quality and fluidity. Recent studies assessing
the surface pressure of meibomian gland lipids using a
Lagmuir trough indicate that incorporation of purified
keratin proteins into the lipid increases the surface pressure
above that of normal meibomian gland lipid [42]. The
authors postulate that a 10 % increase in keratin proteins as
reported by Ong et al. [31] would make the lipid more rigid
and subject to fracture if incorporated into the lipid layer of
the tear film.
Importantly, these new findings suggest alternative
mechanisms for the development of MGD other than
ductal hyperkeratinization and obstruction. First, envir-
onmental stress or other disease mechanisms leading to
increased meibomian gland duct and acinar turnover
may lead to increased protein and desquamated cells
and cellular debris in the central duct altering the quality
and fluidity of the lipid, and potentially leading to mech-
anical obstruction. Such a hypothesis was originally pro-
posed by Korb and Henriquez based on the presence of
squamous cells and debris within MGD excreta [25]. This
is a more likely explanation than the putative hyperkerati-
nization and ductal plugging, particularly since contact
lens wearing alters the aqueous evaporative dynamics of
the ocular surface and may lead to a similar stress re-
sponse observed in the EDED mouse model. Although,
secondary, inflammation-induced hyperkeratinization of
the duct caused by the development of dry eye cannot be
ruled out as a consequence of these environmentally
induced changes in gland function and lipid quality.
Secondly, repeated stress-induced hyperproliferation of
the meibomian gland may lead to early exhaustion of the
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Fig. 4 Effects of desiccating stress on meibomian gland cell proliferation (a and b) and lipid quality (c-h). Cryosections stained for the cell cycling
marker, Ki67 (green) of eyelids from normal mice (a) and mice exposed to 10 days of desiccating stress (b). SRS microscopy of lipid within
cryosections from eyelids of normal mice (c) and the overlay (d) with immunostaining for nuclei (DAPI, red), and actin (Phalloidin, blue) to
identify acini (ac, arrows) and ductules (dt). e, Graph of protein to lipid ratio from different regions of the gland (numbered 1–10), including acini
(ac), ductule (dt) central duct (cd), and extracellular matrix (e). f-h, graph of protein to lipid ratio for control mice (f) and mice exposed to 5 days
(g) and 10 days (h) desiccating stress (different colors represent different mice. Note that in the normal gland there is low glandular proliferation
(a) and a gradual decreasing protein to lipid ratio moving from the acini to the central duct (e and f). By comparison meibomian glands from
mice exposed to desiccating stress show up-regulation of cell cycling (b) and no change in the protein to lipid ratio (g and h)
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progenitor or stem cell population within the gland that is
necessary for maintenance of acinar function. Little is
known about meibomian gland progenitor cells; however,
repeated exposure to environmental stress, such as contact
lens wear or ocular surface drying, may lead to a similar
phenomenon to limbal stem cell deficiency where the gland
can not replace acinar basal cells resulting in loss of acini
and meibomian gland dropout as is seen in ARMGD in the
mouse. With loss of acinar tissue, there also maybe an
imbalance between lipid and ductal cells contributing to
the excreta. This may result in an increase in the protein to
lipid ratio, leading to altered lipid fluidity and a more
rigid lipid on the tear film. Additionally, potential
mechanical blockage of the gland may occur as seen
in ARMGD with the epithelial plugging from ductal
epithelial cells.
Finally, nothing is known about how protein is removed
from the lipid once the acinar cells break down and
release lipid. It is possible that this degradation pathway
specifically involves the acinar cell, and thus as acinar
tissue is lost, the ability to degrade protein in the duct
would be compromised. Additionally, regulatory mech-
anisms controlling protein degradation in the duct may
also be an alternative pathologic target for increasing
the protein to lipid ratio and altering lipid fluidity and
stiffness. Together these alternative mechanisms for the
development of MGD seem more possible than that of
hyperkeratinization of the orifice of the gland leading
to obstruction, dilation and disuse atrophy.
Summary
In this review we have critically evaluated the proposed
pathogenetic mechanism for MGD involving hyperkeratini-
zation of the meibomian gland duct leading to obstruction,
cystic dilation and "disuse" atrophy of the meibomian gland.
In considering this model we have noted several, relevant
clinical and experimental findings that are not entirely con-
sistent, particularly regarding the differences in the meibo-
graphic and biochemical findings in hyperkeratinization
models compared to clinical MGD. New information on
age-related changes in the meibomian gland also suggest
alternative mechanism for the development of MGD and
include the lack of evidence that hyperkeratinization plays a
role in ARMGD, the finding that in both mouse and
humans there is an anterior displacement of the mucocuta-
neous junction and loss of fully keratinized epithelium
around the meibomian gland orifice, and the finding the
desiccating stress induces proliferative changes in the gland
leading to retention of protein the meibomian gland lipid
that could alter lipid fluidity and stiffness. While these new
findings need to be confirmed and extended, they strongly
suggest alternative mechanisms to hyperkeratinization
that may play a major role in the development of
blepharitis-associated MGD.
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